In 2022, the global Mesenchymal Stem Cells Market was valued at USD 3.01 Billion. However, it is projected to experience substantial growth and reach USD 86.28 Billion by 2032, with a remarkable revenue CAGR of 12% during the forecast period. The surge in market revenue can be attributed to several key factors. Firstly, the prevalence of chronic diseases has been increasing, and there is a...